Filana Therapeutics Insider Trades
NASDAQ: FLNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 10 · $749.50K
- Sales
- 0 · $0
- Shares bought / sold
- 1.19M / 0
- Net activity
- Net buying $749,496
Filana Therapeutics insider activity
Over the last 12 months, Filana Therapeutics insiders reported 10 transactions on SEC Form 4: 10 open-market purchases and 0 sales. Insiders bought $749,496 and sold $0 worth of stock, for net insider buying of $749,496. The most recent filing shows Barry Richard (President & CEO) buying 44,851 shares at $0.52 on Nov 18, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put FLNA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
FLNA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 18, 2026 | Anderson Robert Eugene JrDirector | Buy | 19,000 | $9.88K | Form 4 |
| Nov 18, 2026 | Barry RichardPresident & CEO | Buy | 44,851 | $23.32K | Form 4 |
| Nov 17, 2026 | Barry RichardPresident & CEO | Buy | 132,926 | $63.80K | Form 4 |
| Nov 16, 2026 | Schoen EricChief Financial Officer | Buy | 20,000 | $8.40K | Form 4 |
| Nov 16, 2026 | Barry RichardPresident & CEO | Buy | 440,206 | $206.90K | Form 4 |
| Nov 16, 2026 | Cook Robert ChristopherChief Operating& Legal Officer | Buy | 121,575 | $55.92K | Form 4 |
| Sep 30, 2026 | Barry RichardPresident & CEO | Buy | 100,000 | $92.00K | Form 4 |
| Sep 29, 2026 | Barry RichardPresident & CEO | Buy | 206,813 | $186.13K | Form 4 |
| Sep 28, 2026 | Barry RichardPresident & CEO | Buy | 93,091 | $78.20K | Form 4 |
| Nov 24, 2025 | Anderson Robert Eugene JrDirector | Buy | 8,600 | $24.94K | Form 4 |
| Nov 20, 2025 | Barry RichardPresident & CEO | Buy | 150,000 | $414.00K | Form 4 |
| Nov 19, 2025 | Barry RichardPresident & CEO | Buy | 73,385 | $201.81K | Form 4 |
| Sep 30, 2025 | Cook Robert ChristopherChief Operating & Legal Office | Buy | 13,725 | $39.94K | Form 4 |
| Sep 22, 2025 | Barry RichardPresident & CEO | Buy | 7,172 | $16.35K | Form 4 |
| Sep 19, 2025 | Barry RichardPresident & CEO | Buy | 46,908 | $107.42K | Form 4 |
| Sep 19, 2025 | Barry RichardPresident & CEO | Buy | 400 | $900 | Form 4 |
| Sep 18, 2025 | Barry RichardPresident & CEO | Buy | 185,233 | $414.92K | Form 4 |
| Sep 18, 2025 | Barry RichardPresident & CEO | Buy | 5,400 | $11.50K | Form 4 |
| Nov 29, 2024 | Schoen EricChief Financial Officer | Sale | 59,800 | $230.83K | Form 4 |
| Nov 29, 2024 | Schoen EricChief Financial Officer | Sale | 2,000 | $7.64K | Form 4 |
| Nov 29, 2024 | Schoen EricChief Financial Officer | Option exercise | 50,000 | $59.00K | Form 4 |
| Nov 29, 2024 | Kupiec James WilliamChief Medical Officer | Sale | 4,000 | $15.48K | Form 4 |
| May 16, 2024 | ROBERTSON SANFORDDirector | Gift | 5,000 | — | Form 4 |
| May 16, 2024 | ROBERTSON SANFORDDirector | Gift | 5,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4